Cohort study: Exposure to modafinil and armodafinil during pregnancy linked to fetal malformations

20 Oct, 2020 | 01:31h | UTC

Pregnancy and Fetal Outcomes Following Exposure to Modafinil and Armodafinil During Pregnancy – JAMA Internal Medicine (free for a limited period)

Commentaries: Caution in Prescribing Modafinil and Armodafinil to Individuals Who Could Become Pregnant – JAMA Internal Medicine (free for a limited period) AND Narcolepsy Drugs Tied to Increased Risk for Birth Defects – NEJM Journal Watch

Vertical transmission of Zika virus and its outcomes: a Bayesian synthesis of prospective studies

20 Oct, 2020 | 01:30h | UTC

Vertical transmission of Zika virus and its outcomes: a Bayesian synthesis of prospective studies – The Lancet Infectious Diseases

Commentary: Desideratum: a developmentalist view of Zika virus infection – The Lancet Infectious Diseases

Meta-analysis: Evidence-based prevention of Alzheimer’s disease

20 Oct, 2020 | 01:21h | UTC

Evidence-based prevention of Alzheimer’s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials – Journal of Neurology, Neurosurgery & Psychiatry

Commentaries: Biggest risk factors identified to try and prevent Alzheimer’s disease – BMJ AND Systematic review finds ten lifestyle factors that clearly impact the probability of developing Alzheimer’s disease (AD) – Sharp Brains

Commentary on Twitter

Evidence-based #prevention of #Alzheimers disease https://t.co/XOMiEoMlmI via @JNNP_BMJ #dementia @perryd43 @PennilessScribe @u3Y4BDE @SanWren @lfkraus @the_scholar1 @ktanimara @drsharwood @TargetLatino @LilithResists @Joseph_Santoro @liftdupbyangels @mrtom101 @SteveDitchfield pic.twitter.com/T5hqbzmIwi

— Ian Kremer (@LEAD_Coalition) July 24, 2020

Non-respiratory presentations of COVID-19, a clinical review

14 Oct, 2020 | 09:33h | UTC

Non-respiratory presentations of COVID-19, a clinical review – The American Journal of Emergency Medicine

Case report: Sudden irreversible hearing loss post COVID-19

14 Oct, 2020 | 09:24h | UTC

Sudden irreversible hearing loss post COVID-19 – BMJ Case Reports

Commentaries: Coronavirus: Patient has sudden permanent hearing loss – BBC AND First reported UK case of sudden permanent hearing loss linked to COVID-19 – BMJ

Commentary on Twitter

Sudden hearing loss after #COVID19.
Report of 1st UK case and review of the other 4 published reports (must be *extremely rare*)https://t.co/wCkrgHcwKH pic.twitter.com/onQxxYiImb

— Eric Topol (@EricTopol) October 13, 2020

Study: Neurologic manifestations occur in most hospitalized Covid‐19 patients

9 Oct, 2020 | 09:11h | UTC

Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients – Annals of Clinical and Translational Neurology

Commentaries: COVID-19 neurological symptoms emerge in most hospitalized patients, study says AND Many hospitalized COVID-19 patients exhibit neurological symptoms, study finds – News Medical AND More than 80% of people hospitalized for COVID-19 suffer neurological symptoms, from confusion to altered brain function – Business Insider

Cerebral venous thrombosis: A practical guide

8 Oct, 2020 | 08:54h | UTC

Cerebral venous thrombosis: a practical guide – Practical Neurology

Long-term health consequences of COVID-19

6 Oct, 2020 | 00:58h | UTC

Long-term Health Consequences of COVID-19 – JAMA

Commentary on Twitter

Persistent post-COVID symptoms could be the from direct tissue invasion by the virus, profound inflammation & cytokine storm, related immune system damage, hypercoagulable state, or some combination https://t.co/G8tI9U3TaL @CarlosdelRio7 lfcollins_md @PreetiNMalani

— JAMA (@JAMA_current) October 5, 2020

Systematic review: Carotid endarterectomy for symptomatic carotid stenosis

6 Oct, 2020 | 00:10h | UTC

Carotid endarterectomy for symptomatic carotid stenosis – Cochrane Library

Drug-related orthostatic hypotension: Beyond anti-hypertensive medications

2 Oct, 2020 | 09:13h | UTC

Commentary on Twitter

Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications. An open access review … https://t.co/YB0KiEiAtF pic.twitter.com/YzfsmQmtbZ

— Rohan Elliott (@elliott_rohan) September 30, 2020

JAMA Network Series: Medical Specialties and the COVID-19 Pandemic

24 Sep, 2020 | 09:45h | UTC

Editorial: The COVID-19 Pandemic and the JAMA Network

See articles:

Concise review: Management of acute ischemic stroke

22 Sep, 2020 | 09:26h | UTC

Management of Acute Ischemic Stroke – Critical Care Medicine

A case of probable Parkinson’s disease after SARS-CoV-2 infection

17 Sep, 2020 | 09:40h | UTC

A case of probable Parkinson’s disease after SARS-CoV-2 infection – The Lancet Neurology

Commentary on Twitter

Parkinson's disease diagnosed after #SARSCoV2 in a 45 year-old-man https://t.co/SPLKDm1A2U @TheLancetNeuro
This has been reported with many other viruses but appears to be the 1st case with covid, very extensive workup pic.twitter.com/AtQfQXxjtm

— Eric Topol (@EricTopol) September 17, 2020

How COVID-19 can damage the brain

17 Sep, 2020 | 09:36h | UTC

How COVID-19 can damage the brain – Nature

Commentary on Twitter

How COVID-19 can damage the brain https://t.co/uQUS5y9AXU 125 people in the United Kingdom with COVID-19 who had neurological or psychiatric effects. 62% had strokes and haemorrhages, and 31% had altered mental states, such as confusion or prolonged unconsciousness.

— Carlos del Rio (@CarlosdelRio7) September 16, 2020

Multisystem effects of COVID-19: A concise review for practitioners

16 Sep, 2020 | 09:14h | UTC

Multisystem effects of COVID-19: A concise review for practitioners – Postgraduate Medicine

Systematic review: Prediction of poor neurological outcome in comatose survivors of cardiac arrest

15 Sep, 2020 | 08:40h | UTC

Prediction of poor neurological outcome in comatose survivors of cardiac arrest: a systematic review – Intensive Care Medicine

Editorial: ERC‑ESICM guidelines for prognostication after cardiac arrest: time for an update

Commentary on Twitter

Poor neuro-outcome in comatose survivors of CA ->
clinical exam, biomarkers, EEG, neuroimaging reliable predictors within 1st week from ROSC; low/0% FPR but most low sensitivity & risk of bias/confounders: no certainty, multimodal approach prudent #FOAMres https://t.co/GjQNoT1L49 pic.twitter.com/WUZofIslZx

— Intens Care Med (@yourICM) September 11, 2020

International consensus recommendations on the diagnostic work-up for malformations of cortical development

8 Sep, 2020 | 00:58h | UTC

International consensus recommendations on the diagnostic work-up for malformations of cortical development – Nature Reviews Neurology

Systematic review: Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis

2 Sep, 2020 | 09:30h | UTC

Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis – Cochrane Library

Summary: Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis – Cochrane Library

Factors associated with risk of recurrent transient global amnesia

1 Sep, 2020 | 05:53h | UTC

Factors Associated With Risk of Recurrent Transient Global Amnesia – JAMA Neurology (free for a limited period)

#ESCCongress – [Abstract Only] Randomized trial: Low-dose edoxaban in very elderly patients with atrial fibrillation

31 Aug, 2020 | 01:32h | UTC

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation – New England Journal of Medicine

Commentaries: Edoxaban Low-Dose for Elder Care Atrial Fibrillation – ELDERCARE-AF – American College of Cardiology AND ELDERCARE-AF: Edoxaban Superior to Placebo in Preventing Stroke, Systemic Embolism in Elderly Japanese AFib Patients – American College of Cardiology

Commentary on Twitter

Elderly patients with AF who were not candidates for standard doses of oral anticoagulants because of a high risk of bleeding were assigned to receive 15 mg of edoxaban or placebo once daily. Edoxaban was superior to placebo in preventing stroke or systemic embolism. #ESCCongress

— NEJM (@NEJM) August 30, 2020